Eijiro Nagasaki

563 citations
25 papers · 325 indexed · h-index 12
Topics
Immunotherapy and Immune Responses (9 papers)Cancer Diagnosis and Treatment (4 papers)T-cell and B-cell Immunology (4 papers)
Partner nations
JapanUnited States

In The Last Decade

Eijiro Nagasaki

25 papers receiving 321 citations

Peers

Eijiro Nagasaki
Comparison fields: 5 of 49
  • Oncology 183
  • Immunology 147
  • Molecular Biology 105
  • Surgery 51
  • Cancer Research 42
Replace Alexandro Landshammer with:
Alexandro Landshammer Germany
George Locke United States
Andressa S. Laino United States
Kelli A. Connolly United States
Bo Marelli United States
Lillian Sun United States
Debbie Robbrecht Netherlands
Judith Atz Germany
Houssein Abdul Sater United States
Irene Arroyo‐Solera Spain
Eijiro Nagasaki relative to Alexandro Landshammer Germany Alexandro Landshammer's profile →
Citations per field
00.5×1.5×2.0×
Alexandro Landshammer · 1×
Citations per year

Countries citing papers authored by Eijiro Nagasaki

Since Specialization
Citations

This map shows the geographic impact of Eijiro Nagasaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eijiro Nagasaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eijiro Nagasaki more than expected).

Fields of papers citing papers by Eijiro Nagasaki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eijiro Nagasaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eijiro Nagasaki. The network helps show where Eijiro Nagasaki may publish in the future.

Co-authorship network of co-authors of Eijiro Nagasaki

This figure shows the co-authorship network connecting the top 25 collaborators of Eijiro Nagasaki. A scholar is included among the top collaborators of Eijiro Nagasaki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eijiro Nagasaki. Eijiro Nagasaki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 9
2 2
3 4
4 18
5 25
6 24
7 6
8 4
9 11
10 46
11
[Strontium-89 therapy and subarachnoid phenol block successfully eliminated intractable pain of metastasis in the patient with advanced urachal carcinoma].
2
12 23
13 16
14 13
15 3
16 16
17 30
18 11
19
フラボピリドール(HMR1275、サイクリン依存性キナーゼ(CDK)阻止剤)の毎週1時間点滴の第I相臨床試験
1
20
[Simultaneous detection of both non-Hodgkin's lymphoma cells and breast cancer cells in pleural effusion--a case report].
2

About Eijiro Nagasaki

Eijiro Nagasaki is a scholar working on Oncology, Immunology and Gastroenterology, having authored 25 papers that have together received 325 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (9 papers), Cancer Diagnosis and Treatment (4 papers) and T-cell and B-cell Immunology (4 papers). The work is most often cited by research in Immunology (147 citations), Oncology (183 citations) and Cancer Research (42 citations). Eijiro Nagasaki has collaborated with scholars based in Japan and United States. Frequent co-authors include Sadamu Homma, Shigeo Koido, Masaki Ito, Hideo Komita, Akitaka Takahara, Hisao Tajiri, Kazumi Hayashi, Shin Kan, Yuko Kamata and Yukiko Sagawa. Their work appears in journals such as Journal of Clinical Oncology, Blood and The Journal of Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026